The Effect of Mannitol on the Serum Potassium During Craniotomy

Status Completed

Clinical Trial Summary

This is an observational study designed to research the effect of mannitol on the concentration of intraoperative serum potassium in patients undergoing craniotomy, and to guide the safe use of mannitol during craniotomy.

Clinical Trial Description

Patients were assigned to receive 20% mannitol (1g/kg) solution administered intravenously 15-20 minutes at the time of drilling skull.The serum potassium was measured by arterial blood gas analysis before infusion (T0), infusion finished (T1), 15min (T2), 30min (T3), 60min (T4) and 120min (T5) after infusion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03161977
Study type	Observational
Source	The Affiliated Hospital of Xuzhou Medical University
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2017
Completion date	June 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03172702` - Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia	Phase 3
Terminated	`NCT05056727` - A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia	Phase 3
Recruiting	`NCT05766839` - Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age	Phase 2
Completed	`NCT02609841` - POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study	N/A
Recruiting	`NCT06277128` - A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.	Phase 2
Recruiting	`NCT04789239` - OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure	Phase 2
Completed	`NCT05029310` - Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients	Phase 4
Terminated	`NCT04443608` - Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management	Phase 4
Completed	`NCT02607085` - REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study	N/A
Completed	`NCT03283267` - A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)	Phase 1
Recruiting	`NCT06036823` - 5 Versus 10 Units of Insulin in Hyperkalemia Management	Phase 4
Recruiting	`NCT05173584` - Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.	Phase 4
Completed	`NCT05184998` - Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels
Completed	`NCT01737697` - Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia	Phase 3
Completed	`NCT01493024` - Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia	Phase 2
Completed	`NCT04207203` - Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study	N/A
Completed	`NCT05382988` - Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy	Phase 3
Completed	`NCT04217590` - Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects	Phase 3
Recruiting	`NCT03096561` - Measurement of Serum Potassium Rate During Accidental Hypothermia.	N/A
Completed	`NCT03326583` - The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia	Phase 2